Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR)   APRIL 2016 , Volume 10 , Number 2; Page(s) 61 To 69.
 
Paper: 

MICROBIAL AND ANTIBIOTIC SUSCEPTIBILITY PROFILE AMONG CLINICAL SAMPLES OF PATIENTS WITH ACUTE LEUKEMIA

 
 
Author(s):  ABDOLLAHI ALIREZA*, HAKIMI FAEZEH, DOOMANLOU MAHSA, AZADEGAN AZADEH
 
* DEPARTMENT OF PATHOLOGY, SCHOOL OF MEDICINE, IMAM HOSPITAL COMPLEX, TEHRAN, IRAN
 
Abstract: 

Introduction: Preventing and starting early treatment of infections in patients whose immunity system is weak due to malignancies like leukemia can reduce mortality. This study aimed to determine microbial and antibiotic resistance patterns in clinical samples of patients with acute leukemia to start early treatment before the results of clinical tests are known. Subjects and Methods: In this cross-sectional study, the clinical samples of all patients hospitalized with the diagnosis of acute leukemia were cultured and their antibiogram was evaluated. Then, the data were analyzed by SPSS 18 based on the objectives of the study. Results: Of a total of 2,366 samples, 18.95% were reported to be positive blood samples, 22.96% were reported to be urine samples and 36% wound samples. E. coli was the most common bacteria isolated from the blood and urine cultures (34% in blood, 32% in urine culture) while Staphylococcus Aureus was the most common in the wound culture (35%). The highest level of sensitivity in the organisms with positive blood culture was to Ciprofloxacin, while in positive urine and wound culture was to Imipenem. The highest resistance in blood, urine and wound culture was to Cotrimoxazole. Conclusion: According to results obtained from this study, it is necessary to conduct appropriate studies on this issue in specific conditions in our country. The findings of this study can be used in clinics for more accurate diagnosis, more effective treatment before the results of clinical tests are known and also for prevention of infection in cancer patients.

 
Keyword(s): ACUTE LEUKEMIA, ANTIMICROBIAL SUSCEPTIBILITY, CLINICAL FLUIDS, MICROBIAL PROFILE
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

ABDOLLAHI, A., & HAKIMI, F., & DOOMANLOU, M., & AZADEGAN, A. (2016). MICROBIAL AND ANTIBIOTIC SUSCEPTIBILITY PROFILE AMONG CLINICAL SAMPLES OF PATIENTS WITH ACUTE LEUKEMIA. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR), 10(2), 61-69. https://www.sid.ir/en/journal/ViewPaper.aspx?id=511537



Vancouver: Copy

ABDOLLAHI ALIREZA, HAKIMI FAEZEH, DOOMANLOU MAHSA, AZADEGAN AZADEH. MICROBIAL AND ANTIBIOTIC SUSCEPTIBILITY PROFILE AMONG CLINICAL SAMPLES OF PATIENTS WITH ACUTE LEUKEMIA. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR). 2016 [cited 2021July25];10(2):61-69. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=511537



IEEE: Copy

ABDOLLAHI, A., HAKIMI, F., DOOMANLOU, M., AZADEGAN, A., 2016. MICROBIAL AND ANTIBIOTIC SUSCEPTIBILITY PROFILE AMONG CLINICAL SAMPLES OF PATIENTS WITH ACUTE LEUKEMIA. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR), [online] 10(2), pp.61-69. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=511537.



 
  pdf-File
Yearly Visit 43
 
 
Latest on Blog
Enter SID Blog